维普中文期刊产品整合服务
1篇 您的检索式:作者名="Yannis V.Simos"
    题名 作者 年代 出处 被引量
1Trends of nanotechnology in type 2 diabetes mellitus treatment显示文摘There are several therapeutic approaches in type 2 diabetes mellitus(T2DM).When diet and exercise fail to control hyperglycemia,patients are forced to start therapy with antidiabetic agents.However,these drugs present several drawbacks that can affect the course of treatment.The major disadvantages of current oral modalities for the treatment of T2DM are mainly depicted in the low bioavailability and the immediate release of the drug,generating the need for an increase in frequency of dosing.In conjugation with the manifestation of adverse side effects,patient compliance to therapy is reduced.Over the past few years nanotechnology has found fertile ground in the development of novel delivery modalities that can potentially enhance anti-diabetic regimes efficacy.All efforts have been targeted towards two main vital steps:(a)to protect the drug by encapsulating it into a nano-carrier system and(b)efficiently release the drug in a gradual as well as controllable manner.However,only a limited number of studies published in the literature used in vivo techniques in order to support findings.Here we discuss the current disadvantages of modern T2DMmarketed drugs,and the nanotechnology advances supported by in vivo in mouse/rat models of glucose homeostasis.The generation of drug nanocarriers may increase bioavailability,prolong release and therefore reduce dosing and thus,improve patient compliance.This novel approach might substantially improve quality of life for diabetics.Application ofmetal nanoformulations as indirect hypoglycemic agents is also discussed.Yannis V.Simos Konstantinos Spyrou Michaela Patila Niki Karouta Haralambos Stamatis Dimitrios Gournis Evangelia Dounousi Dimitrios Peschos 2021Asian Journal of Pharmaceutical Sciences2021,16,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费